CHD1 and central nervous system cancer: Studies of The Cancer Genome Atlas (TCGA) database showed that lncRNA MATN1-AS1 promotes the progression of gliomas by regulating the miR-200b/c/429-CHD1 axis, suggesting that MATN1-AS1 may be a therapeutic target for glioma (Zhu et al., 2020).